Mizuho cuts ServiceNow stock price target on mixed results By Investing.com

Mizuho cut its ServiceNow price target to $140 from $150 while keeping an Outperform rating, citing mixed first-quarter results and 2Q organic cRPO guidance of about 17.25% YoY constant currency, or 19.5% reported, below some forecasts. ServiceNow lifted its 2026 Now Assist ACV target by 50% to $1.5 billion and now guides to roughly 18.5% organic constant-currency subscription revenue growth, but analyst reactions remain mixed with multiple target cuts. The stock is down 45% over six months and trades around $103 versus a $211 52-week high.

Analysis

The most important read-through is not the near-term noise in ServiceNow; it is that enterprise software demand is still being repriced around AI monetization, but only for vendors that can convert pilots into measurable contract expansion. That creates a bifurcation: the market will keep rewarding names with visible ACV acceleration and punishing anyone whose AI story relies on vague usage growth. In that framework, NOW is more a quality compounding asset than a momentum trade, but the multiple reset means any further deceleration in cRPO can still drive another leg lower because the stock is no longer priced for perfection.

The second-order effect is competitive, not just company-specific. If NOW can lift 2026 AI-related contract targets while preserving margins, it forces peers to defend budget share with either deeper discounts or faster product bundling, which can pressure near-term renewal economics across the workflow and ITSM stack. The acquisition noise also matters: it increases the odds that investors penalize reported growth for several quarters, which usually creates a better entry point later rather than immediately after earnings.

For Tesla/Intel, the headline implies a potential validation point for Intel’s advanced foundry strategy, but it is still one customer comment, not a capacity commitment. If the project is real, the first beneficiaries are likely the adjacent suppliers and tooling ecosystem rather than Intel equity itself, because the market will want proof of yield, ramp speed, and economics before assigning durable foundry value. The risk is that any delay pushes the thesis out by 6-12 months and leaves INTC exposed to a classic “story stock” rerating without operating confirmation.

Key Decisions for Investors

• BUY NOW on weakness only if the stock trades another 5-8% lower: risk/reward improves materially once the market price moves from 'AI execution premium' to 'execution skepticism'; target a 3-6 month holding period and look for stabilization in cRPO before adding size.
• SHORT a basket of lower-quality enterprise software names vs. LONG NOW as a relative-value pair: the setup favors vendors with durable FCF and pricing power if AI spend keeps flowing, but only if the short leg has weaker margin/retention visibility over the next 2 quarters.
• Do not chase INTC on the Tesla comment; if anything, use any post-news strength to fade into an options-defined position. A 1-3 month call spread sale or covered-call overlay makes more sense than outright long equity until there is confirmed volume, yield, and capex disclosure.
• Set a catalyst window around the next 1-2 earnings prints: NOW becomes attractive on evidence that acquisition drag is fading and organic growth re-accelerates; absent that, upside is capped and downside can persist as multiples compress.
• If you want Tesla exposure here, keep it as a volatility trade rather than a fundamentals trade: the foundry headline is too early for a core position, but it can support short-dated upside optionality around follow-up announcements.